Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Ren

Showing results (431-440 of 434) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 434 results.
The Lancet. Gastroenterology & Hepatology|January 14, 2020
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled studyYing-Xuan Chen, Qin-Yan Gao, Tian-Hui Zou, et al.
Cell Reports. Medicine|August 12, 2025
Berberine for preventing colorectal adenoma recurrence and neoplasm occurrence: 6-Year follow-up of a randomized clinical trialYong-Jie Tan, Tian-Hui Zou, Ke Yu, et al.
Medcomm|December 11, 2023
A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancerQiyun Shi, Xiaowei Qi, Peng Tang, et al.
Gastroenterology|February 15, 2022
Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric CancerCheng-Bei Zhou, Si-Yuan Pan, Peng Jin, et al.
Pageof 44

Showing results (431-440 of 434) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 434 results.
The Lancet. Gastroenterology & Hepatology|January 14, 2020
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled studyYing-Xuan Chen, Qin-Yan Gao, Tian-Hui Zou, et al.
Cell Reports. Medicine|August 12, 2025
Berberine for preventing colorectal adenoma recurrence and neoplasm occurrence: 6-Year follow-up of a randomized clinical trialYong-Jie Tan, Tian-Hui Zou, Ke Yu, et al.
Medcomm|December 11, 2023
A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancerQiyun Shi, Xiaowei Qi, Peng Tang, et al.
Gastroenterology|February 15, 2022
Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric CancerCheng-Bei Zhou, Si-Yuan Pan, Peng Jin, et al.
Pageof 44